AI labs are no longer just selling models. Wall Street is becoming the channel
Enterprise AI is being packaged through capital structures and investor networks.📷 Generated editorial visual / Tech&Space
- ★Anthropic and OpenAI form enterprise AI joint ventures
- ★$4B OpenAI raise at $10B valuation
- ★Blackstone, Goldman Sachs anchor Anthropic's $1.5B fund
anthropic and OpenAI are deploying a new playbook: treating enterprise AI as a financial product. The two AI labs have formed joint ventures with asset managers, raising a combined $5.5 billion to market their AI services to corporations. Anthropic’s venture, backed by Blackstone, Hellman & Friedman, and Goldman Sachs, includes a $300 million commitment from each partner, totaling $1.5 billion. OpenAI’s Development Company, meanwhile, has secured $4 billion from 19 investors, including TPG and Brookfield Asset Management, at a $10 billion valuation.
These partnerships are not just about capital—they’re about distribution. Investors like Blackstone and Goldman Sachs will offer their portfolio companies preferred access to Anthropic’s and OpenAI’s AI tools, effectively turning enterprise AI into a leveraged asset. The model mirrors how private equity firms bundle resources for their holdings, but with AI as the core product. As one unnamed source told TechCrunch, the goal is to embed AI into existing workflows, starting with industries like healthcare and finance, where workflows are complex and high-value.
Anthropic, OpenAI and financial giants are selling AI as a distribution channel, not just a tool.
The joint-venture model turns portfolio access into part of the AI product.📷 Generated editorial visual / Tech&Space
The source material also shows that the ventures reflect a broader trend: AI labs are no longer just selling models—they’re selling entire ecosystems. By partnering with asset managers, Anthropic and OpenAI gain direct pipelines to enterprise clients, bypassing traditional sales cycles. The approach also mitigates risk; instead of relying on sporadic enterprise deals, the ventures create recurring revenue streams tied to investors’ portfolios.
For asset managers, the appeal is clear: AI adoption could drive operational efficiencies across their holdings, potentially boosting valuations.
Yet the strategy is not without challenges. Customizing AI for enterprise workflows requires deep integration, often involving months of collaboration between AI engineers and client teams. The ventures’ success hinges on whether these tools can deliver measurable ROI—a tall order in industries like healthcare, where regulatory hurdles and data privacy concerns loom large. If the model works, it could redefine how AI is sold, shifting the focus from one-off contracts to long-term, asset-backed partnerships.
